Feedback Medical brings Bleepa to India
Announces pilot project for rapid, remote diagnosis of tuberculosis
Announces pilot project for rapid, remote diagnosis of tuberculosis
Both parties are expected to invest a total of US $ 1 million to establish the brand
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
BRAFTOVI combination regimen is the first and only targeted therapy approvedby the U.S. FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation
Modernization and supply chain diversity drive new growth
Subscribe To Our Newsletter & Stay Updated